{"id":4375,"date":"2019-02-14T12:38:03","date_gmt":"2019-02-14T12:38:03","guid":{"rendered":"http:\/\/www.caltagmedsystems.co.uk\/information\/?p=4375"},"modified":"2020-03-17T11:14:29","modified_gmt":"2020-03-17T11:14:29","slug":"white-paper-analysis-of-neoantigen-reactive-t-cells-using-the-quickswitch-custom-tetramer-kit","status":"publish","type":"post","link":"https:\/\/www.caltagmedsystems.co.uk\/information\/white-paper-analysis-of-neoantigen-reactive-t-cells-using-the-quickswitch-custom-tetramer-kit\/","title":{"rendered":"White Paper: Analysis of neoantigen-reactive T cells using the QuickSwitch&#x2122; custom tetramer kit"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-4376 alignleft\" src=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/MBL_APRIL_whitepaper_quickswitch-300x238.jpg\" alt=\"\" width=\"300\" height=\"238\" srcset=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/MBL_APRIL_whitepaper_quickswitch-300x238.jpg 300w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/MBL_APRIL_whitepaper_quickswitch.jpg 367w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Kazuhiro Kakimi MD, PhD has been a leader in developing effective immunotherapies against cancer for the last 15 years in Japan.<\/p>\n<p>In this whitepaper, he and his colleagues have reported that the QuickSwitch&#x2122; Custom Tetramers will become an essential tool for studies of neoantigens.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><a class=\"button_large\" href=\"https:\/\/www.caltagmedsystems.co.uk\/downloads\/QS-white-paper-Dr.-Kakimi_final.pdf\">Download White Paper<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h2>Related Blogs:<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/evaluating-the-biological-activity-of-a-cancer-vaccine-with-the-hla-a0201-quickswitch-quant-platform\/\">Evaluating the biological activity of a cancer vaccine with the HLA-A*02:01 QuickSwitch&#x2122; Quant platform<\/a><\/li>\n<li><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/quickswitch-custom-tetramers\/\">QuickSwitch&#x2122; \u2013 Quickly Create Custom Tetramers<\/a><\/li>\n<li><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/high-quality-stock-and-custom-peptides\/\">High-Quality Stock and Custom Peptides<\/a><\/li>\n<\/ul>\n<div><a href=\"https:\/\/www.caltagmedsystems.co.uk\/mbl\/\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-3719 alignright\" src=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/MBLI_logo250x100.jpg\" alt=\"MBL International Logo\" width=\"200\" height=\"80\" \/><\/a>Caltag Medsystems is the UK &amp; Ireland distributor for MBL International. For more information please contact:<\/div>\n<div>T: +44 (0)1280 827460 | E:\u00a0<a href=\"mailto:techsupport@caltagmedsystems.co.uk?subject=From%20the%20MBL%20Email\" data-cke-saved-href=\"mailto:techsupport@caltagmedsystems.co.uk?subject=From%20the%20MBL%20Email\">techsupport@caltagmedsystems.co.uk<\/a><\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Kazuhiro Kakimi MD, PhD has been a leader in developing effective immunotherapies against cancer for the last 15 years in Japan. In this whitepaper, he and his colleagues have reported that the QuickSwitch&#x2122; Custom Tetramers will become an essential tool<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[67,225],"class_list":["post-4375","post","type-post","status-publish","format-standard","hentry","category-tetramer","tag-mbl-international","tag-quickswitch"],"_links":{"self":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/4375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/comments?post=4375"}],"version-history":[{"count":7,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/4375\/revisions"}],"predecessor-version":[{"id":5774,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/4375\/revisions\/5774"}],"wp:attachment":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media?parent=4375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/categories?post=4375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/tags?post=4375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}